SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA
- 1 February 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
Abstract
No abstract availableThis publication has 96 references indexed in Scilit:
- Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II studyEuropean Journal Of Cancer, 1998
- An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinomaEuropean Journal Of Cancer, 1997
- EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factorsEuropean Journal Of Cancer, 1997
- Phase II study of cystemustine in advanced eenal cancerEuropean Journal Of Cancer, 1995
- Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC early clinical trials groupEuropean Journal Of Cancer, 1994
- Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-αEuropean Journal Of Cancer, 1994
- Metabolic response of AH13r rat tumours to cyclophosphamide as monitored by pO2 and pH semi-microelectrodesEuropean Journal Of Cancer, 1993
- Phase II study of oral ftorafur and uracil in patients with advanced renal cell carcinomaEuropean Journal Of Cancer, 1993
- Lack of therapeutic efficacy of tamoxifen in advanced renal cell carcinomaEuropean Journal Of Cancer, 1993
- Vinblastine in metastatic renal cell carcinoma: EORTC phase II Trial 30882European Journal Of Cancer, 1992